Back to Search
Start Over
Copy-number intratumor heterogeneity increases the risk of relapse in chemotherapy-naive stage II colon cancer
- Source :
- The Journal of pathologyReferences. 257(1)
- Publication Year :
- 2021
-
Abstract
- Optimal selection of high-risk patients with stage II colon cancer is crucial to ensure clinical benefit of adjuvant chemotherapy. Here, we investigated the prognostic value of genomic intratumor heterogeneity and aneuploidy for disease recurrence. We combined targeted sequencing, SNP arrays, fluorescence in situ hybridization, and immunohistochemistry on a retrospective cohort of 84 untreated stage II colon cancer patients. We assessed the clonality of copy-number alterations (CNAs) and mutations, CD8
Details
- ISSN :
- 10969896
- Volume :
- 257
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- The Journal of pathologyReferences
- Accession number :
- edsair.doi.dedup.....3d7a54a132a94308932ccada40c1f01e